Relay Therapeutics, Inc. — Director's Dealing 2022

Jun 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Relay Therapeutics, Inc. (RLAY)
CIK: 0001812364
Period of Report: 2022-06-27

Reporting Person: Catinazzo Thomas (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-27	Common Stock	S	300	$20.31	Disposed	52952	Direct

Footnotes

F1: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on June 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2: Includes 47,727 shares underlying RSUs.